Your browser doesn't support javascript.
loading
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.
Blomme, Arnaud; Peter, Coralie; Mui, Ernest; Rodriguez Blanco, Giovanny; An, Ning; Mason, Louise M; Jamieson, Lauren E; McGregor, Grace H; Lilla, Sergio; Ntala, Chara; Patel, Rachana; Thiry, Marc; Kung, Sonia H Y; Leclercq, Marine; Ford, Catriona A; Rushworth, Linda K; McGarry, David J; Mason, Susan; Repiscak, Peter; Nixon, Colin; Salji, Mark J; Markert, Elke; MacKay, Gillian M; Kamphorst, Jurre J; Graham, Duncan; Faulds, Karen; Fazli, Ladan; Gleave, Martin E; Avezov, Edward; Edwards, Joanne; Yin, Huabing; Sumpton, David; Blyth, Karen; Close, Pierre; Murphy, Daniel J; Zanivan, Sara; Leung, Hing Y.
Afiliación
  • Blomme A; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Peter C; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Mui E; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Rodriguez Blanco G; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • An N; Laboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
  • Mason LM; School of Engineering, University of Glasgow, Glasgow, UK.
  • Jamieson LE; Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, UK.
  • McGregor GH; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Lilla S; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Ntala C; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Patel R; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Thiry M; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Kung SHY; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Leclercq M; GIGA-Neurosciences, Unit of Cell and Tissue Biology, University of Liège, Liège, Belgium.
  • Ford CA; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Rushworth LK; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • McGarry DJ; Laboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
  • Mason S; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Repiscak P; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Nixon C; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Salji MJ; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Markert E; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • MacKay GM; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Kamphorst JJ; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Graham D; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Faulds K; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Fazli L; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Gleave ME; CRUK Beatson Institute, Garscube Estate, Glasgow, UK.
  • Avezov E; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
  • Edwards J; Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, UK.
  • Yin H; Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, UK.
  • Sumpton D; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Blyth K; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Close P; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Murphy DJ; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Zanivan S; UK Dementia Research Institute at University of Cambridge, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Leung HY; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Glasgow, UK.
EMBO Mol Med ; 14(3): e14764, 2022 03 07.
Article en En | MEDLINE | ID: mdl-35014179
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antagonistas de Andrógenos Límite: Humans / Male Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antagonistas de Andrógenos Límite: Humans / Male Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido